[Business Wire] – Oragenics, Inc. today announced it has received its first patent approval in Europe for its ProBiora3® products. The approval provides additional protection for ProBiora3’s proprietary blend of three probiotic bacteria, specifically de moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to […]
moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to view […]
[Business Wire] – Oragenics, Inc. announced today that its Exclusive Channel Collaboration with Intrexon Corporation, a synthetic biology company, has produced an exponential increase in the fermentation titer of the target compound MU1140 and the discov moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here […]
[Business Wire] – Oragenics, Inc. , today announced its ProBiora3® tablets intended to freshen breath, whiten teeth and contribute to overall oral health has successfully completed an independent third party review of its Cosmetic Product Safety Report. moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click […]
[Business Wire] – Oragenics, Inc. , today announced Dr. John N. Bonfiglio, President and CEO of Oragenics, Inc., will present an overview of the company and an update on activities at the BIO CEO & Investor Conference in New York City on Tuesday, Februar moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view […]
[Business Wire] – TAMPA, Fla.–(BUSINESSWIRE)– Oragenics, Inc . (OTCQB: OGEN) (OTCBB: OGEN) (the “Companyâ€), a world leader in oral care probiotics, today announced that the Company has entered into a new three year contract … moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to […]
[at noodls] – Oragenics CEO To Present at 6th Annual OneMedForum Investor Conference TAMPA, FL — January 7, 2013 — Oragenics, Inc. (OTCQB and OTCBB: OGEN), today announced Dr. John Bonfiglio, President and CEO of … moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here […]
[Business Wire] – Oragenics, Inc. , today announced Dr. John Bonfiglio, President and CEO of Oragenics, Inc., will present an overview of the company at the 6th Annual OneMedForum in San Francisco on Tuesday, January 8th at 12:00 pm PST. moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is […]
[at noodls] – GRIFFIN SECURITIES INITIATES RESEARCH COVERAGE ON ORAGENICS TAMPA, FL (November 28, 2012), Oragenics, Inc. (OTCQB and OTCBB: OGEN – www.oragenics.com) today announced that Griffin Securities, Inc. has … moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboard […]
